Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel disease
PMID: 38973514
Source: Eur J Gastroenterol Hepatol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL